Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuromelanin, aging, and neuronal vulnerability in Parkinson's disease
Miquel Vila
Movement Disorders (2019) Vol. 34, Iss. 10, pp. 1440-1451
Open Access | Times Cited: 114

Showing 1-25 of 114 citing articles:

In vivo and neuropathology data support locus coeruleus integrity as indicator of Alzheimer’s disease pathology and cognitive decline
Heidi I.L. Jacobs, J. Alex Becker, Kenneth K. Kwong, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 612
Open Access | Times Cited: 171
Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?
Javier Blesa, Guglielmo Foffani, Benjamin Dehay, et al.
Nature reviews. Neuroscience (2021) Vol. 23, Iss. 2, pp. 115-128
Closed Access | Times Cited: 157
The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain
Anna Gąsiorowska, Małgorzata Wydrych, Patrycja Drapich, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 115
The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease
Emma Biondetti, Mathieu Santin, Romain Valabrègue, et al.
Brain (2021) Vol. 144, Iss. 10, pp. 3114-3125
Open Access | Times Cited: 114
Neuromelanin in Parkinson’s Disease: Tyrosine Hydroxylase and Tyrosinase
Toshiharu Nagatsu, Akira Nakashima, Hirohisa Watanabe, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4176-4176
Open Access | Times Cited: 92
Animal models of Parkinson’s disease: bridging the gap between disease hallmarks and research questions
Axelle Dovonou, Cyril Bolduc, Victoria Soto Linan, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 51
The Noradrenergic System in Parkinson’s Disease
Elena Paredes-Rodriguez, Sergio Vegas‐Suárez, Teresa Morera‐Herreras, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 106
The role of neuroimaging in Parkinson’s disease
Natasha Bidesi, Ida Vang Andersen, Albert D. Windhorst, et al.
Journal of Neurochemistry (2021) Vol. 159, Iss. 4, pp. 660-689
Open Access | Times Cited: 88
Parkinson’s disease treatment: past, present, and future
John D. Elsworth
Journal of Neural Transmission (2020) Vol. 127, Iss. 5, pp. 785-791
Open Access | Times Cited: 76
Longitudinal Changes in Neuromelanin MRI Signal in Parkinson's Disease: A Progression Marker
Rahul Gaurav, Lydia Yahia‐Cherif, Nadya Pyatigorskaya, et al.
Movement Disorders (2021) Vol. 36, Iss. 7, pp. 1592-1602
Open Access | Times Cited: 75
Midbrain dopamine oxidation links ubiquitination of glutathione peroxidase 4 to ferroptosis of dopaminergic neurons
Jie Sun, Xiaomin Lin, Dan-Hua Lu, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 10
Open Access | Times Cited: 40
Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson’s disease
Peter Riederer, Toshiharu Nagatsu, Moussa B. H. Youdim, et al.
Journal of Neural Transmission (2023) Vol. 130, Iss. 5, pp. 627-646
Open Access | Times Cited: 35
Neuronal Senescence in the Aged Brain
Shu-Min Chou, Yu‐Hsin Yen, Fang Yuan, et al.
Aging and Disease (2023) Vol. 14, Iss. 5, pp. 1618-1618
Open Access | Times Cited: 28
Neuroinflammation in Parkinson’s Disease: From Gene to Clinic: A Systematic Review
Carlos Castillo-Rangel, Gonzalo Núñez Marín, Karla Aketzalli Hernández-Contreras, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5792-5792
Open Access | Times Cited: 26
Mesoporous silica nanoparticles: Their potential as drug delivery carriers and nanoscavengers in Alzheimer's and Parkinson's diseases
Mohamed S. Attia, Ahmed Saeed Yahya, Nada Abdel Monaem, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 3, pp. 417-432
Open Access | Times Cited: 24
In vivoreduction of age-dependent neuromelanin accumulation mitigates features of Parkinson’s disease
Marta González-Sepúlveda, Joan Compte, Thaïs Cuadros, et al.
Brain (2023) Vol. 146, Iss. 3, pp. 1040-1052
Open Access | Times Cited: 23
Melanin Biopolymers in Pharmacology and Medicine—Skin Pigmentation Disorders, Implications for Drug Action, Adverse Effects and Therapy
Marta Karkoszka, Jakub Rok, Dorota Wrześniok
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 521-521
Open Access | Times Cited: 14
Mechanisms and early efficacy data of caloric restriction and caloric restriction mimetics in neurodegenerative disease
Anchal Trisal, Abhishek Kumar Singh
Neuroscience (2025) Vol. 567, pp. 235-248
Closed Access | Times Cited: 1
Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson’s disease
Peter Riederer, Camelia Monoranu, Sabrina Strobel, et al.
Journal of Neural Transmission (2021) Vol. 128, Iss. 10, pp. 1577-1598
Open Access | Times Cited: 55
Trends in Prevalence Cases and Disability-Adjusted Life-Years of Parkinson’s Disease: Findings from the Global Burden of Disease Study 2019
Qiongqiong Zhong, Feng Zhu
Neuroepidemiology (2022) Vol. 56, Iss. 4, pp. 261-270
Closed Access | Times Cited: 28
The Skin–Brain Axis: From UV and Pigmentation to Behaviour Modulation
Anna A. Ascsillán, Lajos V. Kemény
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6199-6199
Open Access | Times Cited: 6
The Neuromelanin Paradox and Its Dual Role in Oxidative Stress and Neurodegeneration
Alexandra Moreno-García, Alejandra Kun, Miguel Calero, et al.
Antioxidants (2021) Vol. 10, Iss. 1, pp. 124-124
Open Access | Times Cited: 40
What’s That (Blue) Spot on my MRI? Multimodal Neuroimaging of the Locus Coeruleus in Neurodegenerative Disease
Michael A. Kelberman, Shella Keilholz, David Weinshenker
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 39
Discovery of Resorcinol-Based Polycyclic Structures as Tyrosinase Inhibitors for Treatment of Parkinson’s Disease
Qi Li, Jun Mo, Baichen Xiong, et al.
ACS Chemical Neuroscience (2021) Vol. 13, Iss. 1, pp. 81-96
Closed Access | Times Cited: 35
Deep Learning‐Based Neuromelanin MRI Changes of Isolated REM Sleep Behavior Disorder
Rahul Gaurav, Nadya Pyatigorskaya, Emma Biondetti, et al.
Movement Disorders (2022) Vol. 37, Iss. 5, pp. 1064-1069
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top